GLIBA:NASDAQGCI Liberty, Inc. - Series A GCI Group Analysis
Data as of 2026-06-13 - not real-time
$22.44
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Liberty Capital Corporation (GLIBA) has recently completed a corporate name change, a material event that may sharpen investor focus on its Alaska‑centric telecom franchise. Technically, the stock is trading below its short‑term and long‑term moving averages, signaling a bearish trend, but the MACD histogram has turned positive and the RSI is drifting toward oversold territory, suggesting a potential short‑term bounce toward the nearest resistance.
Fundamentally, the company appears deeply undervalued on a value basis, with a price‑to‑book well under half of its book value and a forward P/E dramatically lower than the industry average. While cash flow from operations remains positive, the firm is burdened by high debt relative to cash, negative profit margins, and a sizable drawdown, which tempers the upside implied by its discounted cash‑flow fair‑value estimate.
Fundamentally, the company appears deeply undervalued on a value basis, with a price‑to‑book well under half of its book value and a forward P/E dramatically lower than the industry average. While cash flow from operations remains positive, the firm is burdened by high debt relative to cash, negative profit margins, and a sizable drawdown, which tempers the upside implied by its discounted cash‑flow fair‑value estimate.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Positive MACD histogram indicating short‑term momentum
- RSI approaching oversold levels
- Price near a technical support zone
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Significant valuation gap versus book and peers
- Stable operating cash flow despite earnings losses
- Elevated debt load that may limit upside
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Monopolistic market position in Alaska telecom services
- Low beta and defensive sector characteristics
- Long‑term value upside reflected in DCF fair‑value estimate
Key Metrics & Analysis
Financial Health
Revenue Growth-3.80%
Profit Margin-31.47%
P/E Ratio4.8
ROE-20.41%
ROA2.86%
Debt/Equity60.35
P/B Ratio0.5
Op. Cash Flow$329.0M
Free Cash Flow$115.8M
Industry P/E17.0
Technical Analysis
TrendBearish
RSI37.7
Support$20.25
Resistance$26.51
MA 20$22.87
MA 50$29.68
MA 200$34.78
MACDBullish
VolumeStable
Fear & Greed Index89.86
Valuation
Fair Value$23.13
Target Price$68.00
Upside/Downside203.03%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.32
Volatility74.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.